Delivery Order SPE2DB22D1106-SPE2DB25FEQK0
Award Date
5/28/25
Potential Completion Date
5/29/25
Potential Value
$2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,587.10, was awarded by the Defense Logistics Agency (DLA) for the delivery of Ketorolac 0.5% ophthalmic solution, a medication commonly used to treat eye-related pain and inflammation. The contract is a delivery order, with a firm fixed price pricing type, and has an ultimate completion date of December 13, 2024. This award is not...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order contract valued at $7,542.83 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4564247323 - Ketorolac 0.5% Ophthalmic Solution 5ML. The contract has an ultimate completion date of April 12, 2024. This delivery order is issued under Amerisourcebergen's single-award indefinite delivery contract with DLA valued up to $999,999,999.00 through December 31, 2025, which serves...
This federal contract award, valued at $4,911.09, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ketorolac 0.5% Ophthalmic Solution, a medication used to treat eye pain and inflammation. This is a Firm Fixed Price Delivery Order contract with a completion date of January 29, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp...
This federal contract award is for the delivery of Ketorolac 0.4% ophthalmic solution, a prescription eye medication, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on a firm fixed-price basis for a total ceiling value of $2,047.08. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 2025. This...
This is a Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 10 ml bottles of Ketorolac 0.5% ophthalmic solution, with a ceiling value of $1,154.81 and a completion date of April 16, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of Ketorolac 0.5% ophthalmic solution in 10 mL vials. The contract has a ceiling value of $2,520.00 and is a delivery order placed under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, which is valued at up to $999,999,999.00 through December 31, 2025. The DLA IDC serves as the primary vehicle for Amerisourcebergen to deliver a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of ketorolac 0.5% ophthalmic solution in 10 ml bottles. The $3,564.79 Firm Fixed Price Delivery Order was awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense, on April 15, 2024, with a planned completion date of April 16, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC)...
This federal contract award, with ID SPE2DX15D1022|SPE2DX24FVEMP, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Ketorolac 0.4% ophthalmic solution, a pain management medication, with a ceiling value of $3,540.13. The contract is a Firm Fixed Price Delivery Order, with a performance period ending on March 11, 2024. Amerisourcebergen Drug Corp is a subsidiary of Cencora,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,416.00 firm fixed-price delivery order is for the supply of Ketorolac 0.5% ophthalmic solution 5ml. The contract has an ultimate completion date of October 28, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Ketorolac 30 mg/mL vials. The contract has a firm fixed price, with a ceiling value of $1,874.80, and an ultimate completion date of September 3, 2024. The contract is not set-aside. Amerisourcebergen, through its extensive supply chain network, will provide this critical pharmaceutical product to support various military...